These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2130928)

  • 1. Platelet prothrombinase in health and disease.
    Crook M
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):167-74. PubMed ID: 2130928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet membrane involvement in blood coagulation.
    Hemker HC; van Rijn JL; Rosing J; van Dieijen G; Bevers EM; Zwaal RF
    Blood Cells; 1983; 9(2):303-17. PubMed ID: 6661560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cell generation of thrombin via functional prothrombinase assembly.
    VanDeWater L; Tracy PB; Aronson D; Mann KG; Dvorak HF
    Cancer Res; 1985 Nov; 45(11 Pt 1):5521-5. PubMed ID: 4053025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles.
    Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA
    Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of phospholipids in hemostasis].
    Sletnes KE
    Tidsskr Nor Laegeforen; 1993 Aug; 113(18):2238-41. PubMed ID: 8362386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of procoagulant binding sites on the platelet surface.
    Bevers EM; Rosing J; Zwaal RF
    Adv Exp Med Biol; 1985; 192():359-71. PubMed ID: 3914834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of prothrombinase activity by protein S.
    van 't Veer C; Butenas S; Golden NJ; Mann KG
    Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of platelet-derived factor Va to thrombin generation on immobilized collagen- and fibrinogen-adherent platelets.
    Briedé JJ; Heemskerk JW; van't Veer C; Hemker HC; Lindhout T
    Thromb Haemost; 2001 Mar; 85(3):509-13. PubMed ID: 11307823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activation and blood coagulation.
    Heemskerk JW; Bevers EM; Lindhout T
    Thromb Haemost; 2002 Aug; 88(2):186-93. PubMed ID: 12195687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired platelet procoagulant mechanisms in patients with bleeding disorders.
    Weiss HJ
    Semin Thromb Hemost; 2009 Mar; 35(2):233-41. PubMed ID: 19408196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merocyanine 540 as a fluorescent probe of altered membrane phospholipid asymmetry in activated whole blood platelets.
    Watala C; Waczulikova I; Wieclawska B; Rozalski M; Gresner P; Gwoździński K; Mateasik A; Sikurova L
    Cytometry; 2002 Nov; 49(3):119-33. PubMed ID: 12442312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.
    Tomer A
    J Biol Regul Homeost Agents; 2004; 18(2):172-7. PubMed ID: 15471223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of activated protein C by platelets.
    Jane SM; Mitchell CA; Hau L; Salem HH
    J Clin Invest; 1989 Jan; 83(1):222-6. PubMed ID: 2910909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived microvesicles and activated platelets express factor Xa activity.
    Holme PA; Brosstad F; Solum NO
    Blood Coagul Fibrinolysis; 1995 Jun; 6(4):302-10. PubMed ID: 7548677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of the binding for prothrombinase at the platelet surface as revealed by lipolytic enzymes.
    Bevers EM; Comfurius P; Zwaal RF
    Eur J Biochem; 1982 Feb; 122(1):81-5. PubMed ID: 7060571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V: a platelet cytoskeletal associated protein.
    Tuszynski GP; Walsh PN
    Haematologia (Budap); 1984; 17(1):67-76. PubMed ID: 6427071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between calpain-mediated cytoskeletal degradation and expression of platelet procoagulant activity. A role for the platelet membrane-skeleton in the regulation of membrane lipid asymmetry?
    Verhallen PF; Bevers EM; Comfurius P; Zwaal RF
    Biochim Biophys Acta; 1987 Sep; 903(1):206-17. PubMed ID: 2820487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both the high affinity thrombin receptor (GPIb-IX-V) and GPIIb/IIIa are implicated in expression of thrombin-induced platelet procoagulant activity.
    Dicker IB; Pedicord DL; Seiffert DA; Jamieson GA; Greco NJ
    Thromb Haemost; 2001 Oct; 86(4):1065-9. PubMed ID: 11686325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.